Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Scott

Showing results (1461-1470 of 1,509) with videos related to

Pageof 151
Sort By:
Hepatology (Baltimore, Md.)|October 21, 2015
Costs and consequences: Hepatitis C seroprevalence in the military and its impact on potential screening strategiesDavid M Brett-Major, Kevin D Frick, Jennifer A Malia, et al.
Nature Communications|February 5, 2024
Leukaemia exposure alters the transcriptional profile and function of BCR::ABL1 negative macrophages in the bone marrow nicheAmy Dawson, Martha M Zarou, Bodhayan Prasad, et al.
Military Medicine|July 11, 2020
Hepatitis B seroprevalence in the U.S. military and its impact on potential screening strategiesPaul T Scott, Robert L Cohen, David M Brett-Major, et al.
Mabs|July 8, 2025
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studiesFrank R Brennan, J Ryan Polli, Jean Sathish, et al.
The Lancet. Infectious Diseases|August 17, 2024
Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trialKayvon Modjarrad, Paul T Scott, Melanie McCauley, et al.
The Journal of Infectious Diseases|May 11, 2022
Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019Shilpa Hakre, Ines Lakhal-Naouar, David B King, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 2, 2024
Clinical, molecular, and drug resistance epidemiology of HIV in Jordan, 2019-2021: A national studyFaris G Bakri, Heyam H Mukattash, Hiam Esmeiran, et al.
The Journal of Clinical Investigation|February 6, 2019
RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growthShaikamjad Umesalma, Courtney A Kaemmer, Jordan L Kohlmeyer, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 5, 2021
Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19Daniel Munblit, Polina Bobkova, Ekaterina Spiridonova, et al.
The Lancet. Microbe|May 18, 2024
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trialBrittany L Ober Shepherd, Paul T Scott, Jack N Hutter, et al.
Pageof 151

Showing results (1461-1470 of 1,509) with videos related to

Sort By:
Pageof 151
Hepatology (Baltimore, Md.)|October 21, 2015
Costs and consequences: Hepatitis C seroprevalence in the military and its impact on potential screening strategiesDavid M Brett-Major, Kevin D Frick, Jennifer A Malia, et al.
Nature Communications|February 5, 2024
Leukaemia exposure alters the transcriptional profile and function of BCR::ABL1 negative macrophages in the bone marrow nicheAmy Dawson, Martha M Zarou, Bodhayan Prasad, et al.
Military Medicine|July 11, 2020
Hepatitis B seroprevalence in the U.S. military and its impact on potential screening strategiesPaul T Scott, Robert L Cohen, David M Brett-Major, et al.
Mabs|July 8, 2025
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studiesFrank R Brennan, J Ryan Polli, Jean Sathish, et al.
The Lancet. Infectious Diseases|August 17, 2024
Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trialKayvon Modjarrad, Paul T Scott, Melanie McCauley, et al.
The Journal of Infectious Diseases|May 11, 2022
Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019Shilpa Hakre, Ines Lakhal-Naouar, David B King, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 2, 2024
Clinical, molecular, and drug resistance epidemiology of HIV in Jordan, 2019-2021: A national studyFaris G Bakri, Heyam H Mukattash, Hiam Esmeiran, et al.
The Journal of Clinical Investigation|February 6, 2019
RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growthShaikamjad Umesalma, Courtney A Kaemmer, Jordan L Kohlmeyer, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 5, 2021
Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19Daniel Munblit, Polina Bobkova, Ekaterina Spiridonova, et al.
The Lancet. Microbe|May 18, 2024
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trialBrittany L Ober Shepherd, Paul T Scott, Jack N Hutter, et al.
Pageof 151